[Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
H C
HC
Diener
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D015201:Meta-Analysis as Topic; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012306:Risk; D020521:Stroke / Q000517:prevention & control*
D010726:Phosphodiesterase Inhibitors; D010919:Placebos; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin